Gildy V. Babiera

14.8k citations

184 papers · 9.4k indexed · 1 hit paper · h-index 57

Cancer Research top 0.05%
Pathology and Forensic Medicine top 0.1%
Surgery top 0.5%
Oncology top 0.5%
Pulmonary and Respiratory Medicine top 2%

Co-authors: Kelly K. Hunt Henry M. Kuerer Funda Meric‐Bernstam Merrick I. Ross Isabelle Bedrosian S. Eva Singletary Barry W. Feig Frederick C. Ames
Topics: Breast Cancer Treatment Studies (152 papers)Breast Lesions and Carcinomas (93 papers)Breast Implant and Reconstruction (68 papers)
Cited by: Cancer Research Pathology and Forensic Medicine Oncology
Journals: Journal of Clinical OncologySHILAP Revista de lepidopterologíaJNCI Journal of the National Cancer Institute
Partner nations: United States United Kingdom Switzerland

In The Last Decade

Gildy V. Babiera

182 papers receiving 9.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection

2016 578 citations Abigail S. Caudle, Savitri Krishnamurthy et al. profile →

Peers

Countries citing papers authored by Gildy V. Babiera

Since Specialization

Citations

This map shows the geographic impact of Gildy V. Babiera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gildy V. Babiera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gildy V. Babiera more than expected).

Fields of papers citing papers by Gildy V. Babiera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gildy V. Babiera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gildy V. Babiera. The network helps show where Gildy V. Babiera may publish in the future.

Co-authorship network of co-authors of Gildy V. Babiera

This figure shows the co-authorship network connecting the top 25 collaborators of Gildy V. Babiera. A scholar is included among the top collaborators of Gildy V. Babiera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gildy V. Babiera. Gildy V. Babiera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evolution in practice patterns of axillary management following mastectomy in patients with 1–2 positive sentinel nodes 2019 ·Breast Cancer Research and Treatment ·Anna Weiss,Heather Lin,Gildy V. Babiera,Isabelle Bedrosian,Simona F. Shaitelman,Yu Shen,Henry M. Kuerer,Elizabeth A. Mittendorf,Abigail S. Caudle,Kelly K. Hunt,Rosa F. Hwang	21
2	Lumpectomy Plus Hormone or Radiation Therapy Alone for Women Aged 70 Years or Older With Hormone Receptor–Positive Early Stage Breast Cancer in the Modern Era: An Analysis of the National Cancer Database 2019 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown),Heather Lin,Isabelle Bedrosian,Nina Tamirisa,Gildy V. Babiera,Yu Shen,Simona F. Shaitelman	35
3	Factors associated with improved outcomes for metastatic inflammatory breast cancer patients 2018 ·Breast Cancer Research and Treatment ·Anna Weiss,(unknown),Heather Lin,Yu Shen,(unknown),Simona F. Shaitelman,Wendy A. Woodward,Vicente Valero,Naoto T. Ueno,Isabelle Bedrosian,Gildy V. Babiera	14
4	4-1BB–Enhanced Expansion of CD8+ TIL from Triple-Negative Breast Cancer Unveils Mutation-Specific CD8+ T Cells 2017 ·Cancer Immunology Research ·Michiko Harao,Marie-Andrée Forget,Jason Roszik,Hui Gao,Gildy V. Babiera,Savitri Krishnamurthy,Jessica Chacon,Shumin Li,Elizabeth A. Mittendorf,Sarah M. DeSnyder,(unknown),Chantale Bernatchez,Naoto T. Ueno,Laszlo Radvanyi,Luis M. Vence,Cara Haymaker,James M. Reuben	49
5	Disparities in the Use of Postmastectomy Radiation Therapy for Inflammatory Breast Cancer 2016 ·International Journal of Radiation OncologyBiologyPhysics ·Catherine Loveland‐Jones,Heather Lin,Yu Shen,Isabelle Bedrosian,Simona F. Shaitelman,Henry M. Kuerer,Wendy A. Woodward,Naoto T. Ueno,Vicente Valero,Gildy V. Babiera	6
6	Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ? 2015 ·Annals of Surgical Oncology ·Ashleigh M. Francis,Christine E. Haugen,(unknown),(unknown),Min Yi,Elizabeth A. Mittendorf,Isabelle Bedrosian,Abigail S. Caudle,Gildy V. Babiera,Savitri Krishnamurthy,Henry M. Kuerer,Kelly K. Hunt	48
7	Influence of Biospecimen Variables on Proteomic Biomarkers in Breast Cancer 2014 ·Clinical Cancer Research ·Funda Meric‐Bernstam,Argun Akçakanat,Huiqin Chen,Ayşegül A. Şahin,Emily Tarco,Selin Çarkaci,Beatriz E. Adrada,Gopal K. Singh,Kim‐Anh Do,(unknown),Elizabeth A. Mittendorf,Gildy V. Babiera,Isabelle Bedrosian,Rosa F. Hwang,Savitri Krishnamurthy,W. Fraser Symmans,Ana M. González-Angulo,Gordon B. Mills	40
8	Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy 2012 ·Breast Cancer Research ·Laura S. Dominici,Elizabeth A. Mittendorf,Xumei Wang,Jun Liu,Henry M. Kuerer,Kelly K. Hunt,Abenaa M. Brewster,Gildy V. Babiera,Thomas A. Buchholz,Funda Meric‐Bernstam,Isabelle Bedrosian	37
9	Incorporation of Sentinel Lymph Node Metastasis Size Into a Nomogram Predicting Nonsentinel Lymph Node Involvement in Breast Cancer Patients With a Positive Sentinel Lymph Node 2011 ·Annals of Surgery ·Elizabeth A. Mittendorf,Kelly K. Hunt,Judy C. Boughey,Roland L. Bassett,Amy C. Degnim,Robyn K. Harrell,Min Yi,Funda Meric‐Bernstam,Merrick I. Ross,Gildy V. Babiera,Henry M. Kuerer,Rosa F. Hwang	110
10	The effect of under-treatment of breast cancer in women 80 years of age and older 2010 ·Critical Reviews in Oncology/Hematology ·Barbara L. van Leeuwen,Kari M. Rosenkranz,Liang Feng,Isabelle Bedrosian,(unknown),Kelly K. Hunt,(unknown),Merrick I. Ross,S. Eva Singletary,Gildy V. Babiera	65
11	Does Blue Dye Contribute to Success of Sentinel Node Mapping for Breast Cancer? 2010 ·Annals of Surgical Oncology ·Taewoo Kang,Min Yi,Kelly K. Hunt,Elizabeth A. Mittendorf,Gildy V. Babiera,Henry M. Kuerer,Isabelle Bedrosian,Rosa F. Hwang,Anthony Lucci,Funda Meric‐Bernstam	23
12	Intra-Individual Comparison of Lymphatic Drainage Patterns Using Subareolar and Peritumoral Isotope Injection for Breast Cancer 2009 ·Annals of Surgical Oncology ·Regina M. Fearmonti,Isis Gayed,(unknown),Isabelle Bedrosian,Kelly K. Hunt,Funda Meric‐Bernstam,Barry W. Feig,(unknown),Carla L. Warneke,Gildy V. Babiera	1
13	Utility of ultrasound and fine-needle aspiration biopsy of the axilla in the assessment of invasive lobular carcinoma of the breast 2007 ·The American Journal of Surgery ·Judy C. Boughey,Lavinia P. Middleton,(unknown),(unknown),Bruno D. Fornage,Kelly K. Hunt,Gildy V. Babiera,Peter J. Dempsey,Isabelle Bedrosian	38
14	The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: How young is “young”? 2006 ·International Journal of Radiation OncologyBiologyPhysics ·Julia Oh,Mark Bonnen,Elesyia D. Outlaw,Naomi R. Schechter,George H. Perkins,Eric A. Strom,Gildy V. Babiera,Mary Jane Oswald,Pamela K. Allen,Howard D. Thames,Thomas A. Buchholz	44
15	Biphasic metaplastic sarcomatoid carcinoma of the breast 2006 ·Annals of Oncology ·Bryan T. Hennessy,Sharon H. Giordano,Kristine Broglio,Zhenfeng Duan,J.M. Trent,Thomas A. Buchholz,Gildy V. Babiera,Gabriel N. Hortobágyi,Vicente Valero	165
16	Impact of concurrent proliferative high‐risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast‐conserving therapy 2005 ·Cancer ·(unknown),W. Fraser Symmans,Gildy V. Babiera,S. Eva Singletary,Banu Arun,Nour Sneige,Lajos Pusztai,Thomas A. Buchholz,Ayşegül A. Şahin,Kelly K. Hunt,Funda Meric‐Bernstam,Merrick I. Ross,Frederick C. Ames,Henry M. Kuerer	18
17	Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ 2004 ·Cancer ·Tina Yen,Kelly K. Hunt,Nadeem Q. Mirza,Eva Thomas,S. Eva Singletary,Gildy V. Babiera,Funda Meric‐Bernstam,Thomas A. Buchholz,Barry W. Feig,Merrick I. Ross,Frederick C. Ames,Richard L. Theriault,Henry M. Kuerer	40
18	Positive surgical margins and ipsilateral breast tumor recurrence predict disease‐specific survival after breast‐conserving therapy 2003 ·Cancer ·Funda Meric,Nadeem Q. Mirza,Georges Vlastos,Thomas A. Buchholz,Henry M. Kuerer,Gildy V. Babiera,S. Eva Singletary,Merrick I. Ross,Frederick C. Ames,Barry W. Feig,Savitri Krishnamurthy,George H. Perkins,Marsha D. McNeese,Eric A. Strom,Vicente Valero,Kelly K. Hunt	158
19	Intraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with breast-conserving surgery 2003 ·The American Journal of Surgery ·Anees B. Chagpar,Tina Yen,Ayşegül A. Şahin,Kelly K. Hunt,Gary J. Whitman,Frederick C. Ames,Merrick I. Ross,Funda Meric‐Bernstam,Gildy V. Babiera,S. Eva Singletary,Henry M. Kuerer	95
20	Treatment and outcome of patients with intracystic papillary carcinoma of the breast 2002 ·The American Journal of Surgery ·Carmen C. Solórzano,Lavinia P. Middleton,Kelly K. Hunt,Nadeem Q. Mirza,Funda Meric,Henry M. Kuerer,Merrick I. Ross,Frederick C. Ames,Barry W. Feig,Raphael E. Pollock,S. Eva Singletary,Gildy V. Babiera	113

About Gildy V. Babiera

Gildy V. Babiera is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology, having authored 184 papers that have together received 9.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (152 papers), Breast Lesions and Carcinomas (93 papers) and Breast Implant and Reconstruction (68 papers). The work is most often cited by research in Cancer Research (7.1k citations), Pathology and Forensic Medicine (4.6k citations) and Oncology (3.6k citations). Gildy V. Babiera has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Kelly K. Hunt, Henry M. Kuerer, Funda Meric‐Bernstam, Merrick I. Ross, Isabelle Bedrosian, S. Eva Singletary, Barry W. Feig, Frederick C. Ames, Elizabeth A. Mittendorf and Thomas A. Buchholz. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact